APA引用形式

Curtis, J. R., Lee, E. B., Kaplan, I. V., Kwok, K., Geier, J., Benda, B., . . . Riese, R. (2016). Tofacitinib, an oral Janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical development programme. Ann Rheum Dis.

シカゴスタイル引用形

Curtis, Jeffrey R., Eun Bong Lee, Irina V. Kaplan, Kenneth Kwok, Jamie Geier, Birgitta Benda, Koshika Soma, Lisy Wang, , Richard Riese. "Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancies Across the Rheumatoid Arthritis Clinical Development Programme." Ann Rheum Dis 2016.

MLA引用形式

Curtis, Jeffrey R., et al. "Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancies Across the Rheumatoid Arthritis Clinical Development Programme." Ann Rheum Dis 2016.

警告: この引用は必ずしも正確ではありません.